Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Privia Health Group (PRVA) Stock Forecast & Price Target

Privia Health Group logo
$22.79 +0.15 (+0.66%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$22.58 -0.21 (-0.93%)
As of 05/22/2026 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Privia Health Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
3
Buy
11

Based on 14 Wall Street analysts who have issued ratings for Privia Health Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for PRVA.

Consensus Price Target

$31.23
37.04% Upside
According to the 14 analysts' twelve-month price targets for Privia Health Group, the average price target is $31.23. The highest price target for PRVA is $36.00, while the lowest price target for PRVA is $25.00. The average price target represents a forecasted upside of 37.04% from the current price of $22.79.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for PRVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Privia Health Group and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRVA Analyst Ratings Over Time

TypeCurrent Forecast
5/23/25 to 5/23/26
1 Month Ago
4/23/25 to 4/23/26
3 Months Ago
2/22/25 to 2/22/26
1 Year Ago
5/23/24 to 5/23/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
11 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$31.23$31.31$30.54$27.38
Forecasted Upside37.04% Upside33.22% Upside38.87% Upside19.79% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyBuy

PRVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PRVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Privia Health Group Stock vs. The Competition

TypePrivia Health GroupMedical CompaniesBroader Market
Consensus Rating Score
2.79
2.30
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside37.04% Upside1,715.40% Upside15.10% Upside
News Sentiment Rating
Positive News

See Recent PRVA News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/8/2026 DowngradeHold (C)Hold (C-)
5/8/2026
Richard Close
Richard Close
1 of 5 stars
Lower TargetBuy$35.00 ➝ $34.00+47.22%
4/8/2026
Evercore Inc logo
Evercore
3 of 5 stars
 Set Target$26.00+15.86%
3/25/2026Boost TargetEqual Weight$23.00 ➝ $25.00+18.88%
3/3/2026Lower TargetBuy$34.00 ➝ $32.00+35.71%
3/2/2026Boost TargetBuy$31.00 ➝ $33.00+38.95%
2/26/2026Reiterated RatingBuy$32.00+28.46%
2/26/2026Reiterated RatingOverweight$36.00+44.52%
1/9/2026Initiated CoverageOutperform$31.00+33.91%
1/6/2026 Set Target$31.00+28.42%
12/4/2025Reiterated RatingOverweight$32.00+31.84%
11/13/2025Boost TargetOverweight$32.00 ➝ $33.00+37.30%
11/13/2025Initiated CoverageOutperform$30.00+23.86%
11/7/2025Boost TargetMarket Outperform$30.00 ➝ $31.00+29.63%
8/19/2025 UpgradeStrong SellHold
4/15/2025Boost TargetOutperform$24.00 ➝ $26.00+8.11%
4/10/2025Reiterated RatingBuy$30.00 ➝ $30.00+30.15%
12/16/2024Initiated CoverageOutperform$25.00+19.27%
10/11/2024 Initiated CoverageOverweight$23.00+34.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 01:57 PM ET.


PRVA Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Privia Health Group is $31.23, with a high forecast of $36.00 and a low forecast of $25.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PRVA shares.

According to analysts, Privia Health Group's stock has a predicted upside of 37.04% based on their 12-month stock forecasts.

Over the previous 90 days, Privia Health Group's stock had 1 downgrade by analysts.

Privia Health Group has been rated by research analysts at Barclays, Canaccord Genuity Group, Citigroup, Evercore, Jefferies Financial Group, Piper Sandler, Truist Financial, and Weiss Ratings in the past 90 days.

Analysts like Privia Health Group more than other "medical" companies. The consensus rating for Privia Health Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how PRVA compares to other companies.


This page (NASDAQ:PRVA) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners